Systemic toxicity to betamethasone ointment.

Author: AliyevRahim, FinstererJosef

Paper Details 
Original Abstract of the Article :
Topically applied betamethasone for actinic keratosis may trigger systemic side effects. Systemic side effects of topical betamethasone may completely resolve after discontinuation of the causative agent. A 59-year-old male patient with scalp actinic keratosis developed fatigue and the need to sleep...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495834/

データ提供:米国国立医学図書館(NLM)

Topical Betamethasone: A Cautionary Tale

Topical medications are often considered a safe and effective treatment option, but it's important to be aware of the potential for systemic side effects. This research highlights a case study where a patient developed systemic side effects after using topical betamethasone for actinic keratosis. The authors emphasize the importance of careful monitoring and prompt discontinuation of the causative agent if systemic side effects occur. This study serves as a reminder that even topical medications can have unexpected consequences.

Systemic Side Effects: An Unexpected Oasis in the Desert of Topical Therapy

This research highlights the potential for systemic side effects from topical medications, even those typically considered safe and effective. The authors present a case study where a patient developed systemic side effects after using topical betamethasone for actinic keratosis. The study emphasizes the importance of careful monitoring and prompt discontinuation of the causative agent if systemic side effects occur. This research underscores the need for vigilance in observing patients and recognizing potential adverse reactions.

Navigating the Risks of Topical Medications: A Guide for Patients

This research provides a valuable reminder that even topical medications can have unexpected consequences. The authors present a case study where a patient developed systemic side effects after using topical betamethasone for actinic keratosis. This information empowers patients to proactively communicate any unusual symptoms or side effects to their healthcare providers, potentially preventing further complications.

Dr. Camel's Conclusion

This research highlights the potential for systemic side effects from topical medications, even those typically considered safe and effective. The study emphasizes the importance of careful monitoring and prompt discontinuation of the causative agent if systemic side effects occur. This research underscores the need for vigilance in observing patients and recognizing potential adverse reactions.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-10-01
Further Info :

Pubmed ID

32983466

DOI: Digital Object Identifier

PMC7495834

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.